In Ovations Holdings Inc. (INOH)

[perezpennies]

In Ovations Holdings, Inc. Has Appointed Mel Ehrlich, Ph.D. as a Director and Vice-President of Technology Effective April 28, 2014

Dr. Ehrlich is CEO of Nano Biomed, Inc., a company which has licensed patented nanoparticle technologies in which the nanoparticles deliver nitric oxide (NO). The Nano NO has been tested on animals for applications such as accelerated wound healing and sepsis. He is also CEO of Cytest Labs, Inc. Cytest Labs develops optical scanners using Ultra-Violet (UV) light and a pattern recognition computer to measure and analyze human body cell parameters. Cellular material is obtained from lung cells from deep early morning coughs. The system is designed for the early detection of lung cancer.